000 01253 a2200373 4500
005 20250512153239.0
264 0 _c19711215
008 197112s 0 0 eng d
022 _a0033-3190
024 7 _a10.1159/000286071
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKnopp, W
245 0 0 _aMan's tripartite brain and psychosomatic medicine.
_h[electronic resource]
260 _bPsychotherapy and psychosomatics
_c1970
300 _a130-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAcute Disease
650 0 4 _aAdolescent
650 0 4 _aBrain
_xphysiopathology
650 0 4 _aEmotions
_xdrug effects
650 0 4 _aEvaluation Studies as Topic
650 0 4 _aHaloperidol
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNeurophysiology
650 0 4 _aPrognosis
650 0 4 _aPsychiatric Status Rating Scales
650 0 4 _aPsychophysiologic Disorders
_xphysiopathology
650 0 4 _aSchizophrenia
_xdrug therapy
650 0 4 _aTourette Syndrome
_xdrug therapy
650 0 4 _aTrifluoperazine
_xtherapeutic use
773 0 _tPsychotherapy and psychosomatics
_gvol. 18
_gno. 1
_gp. 130-6
856 4 0 _uhttps://doi.org/10.1159/000286071
_zAvailable from publisher's website
999 _c5287932
_d5287932